Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8954)
All Articles published online
|
Publishing Process of This Article
|
Mar 18, 2016 (publication date) through May 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Reiter FP, Wimmer R, Wottke L, Artmann R, Nagel JM, Carranza MO, Mayr D, Rust C, Fickert P, Trauner M, Gerbes AL, Hohenester S, Denk GU. Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4-/- mouse model. World J Hepatol 2016; 8(8): 401-410 [PMID: 27004088 DOI: 10.4254/wjh.v8.i8.401] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i8/401.htm |
| Number | Citing Articles |
| 1 |
Juanhan Liu, Wenbin Gong, Peizhao Liu, Yangguang Li, Haiyang Jiang, Xiuwen Wu, Yun Zhao, Jianan Ren. Macrophages-microenvironment crosstalk in fibrostenotic inflammatory bowel disease: from basic mechanisms to clinical applications. Expert Opinion on Therapeutic Targets 2022; 26(11): 1011 doi: 10.1080/14728222.2022.2161889
|
| 2 |
Vanessa Hartwig, Bedair Dewidar, Tao Lin, Anne Dropmann, Christoph Ganss, Mark Andreas Kluth, Nils Tappenbeck, Lysann Tietze, Bruno Christ, Markus Frank, Roger Vogelmann, Matthias Philip Alexander Ebert, Steven Dooley. Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice. Archives of Toxicology 2019; 93(9): 2645 doi: 10.1007/s00204-019-02533-3
|
| 3 |
Yang Xu, Feng Liu, Di He, Lei Han, Xiaoyu Zheng, Mingdao Hu, Peng Chen. Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10. Immunobiology 2023; 228(2): 152315 doi: 10.1016/j.imbio.2022.152315
|
| 4 |
Hayato Urushima, Hideto Yuasa, Tsutomu Matsubara, Noriyuki Kuroda, Yaiko Hara, Kouji Inoue, Kenjiro Wake, Tetsuji Sato, Scott L. Friedman, Kazuo Ikeda. Activation of Hepatic Stellate Cells Requires Dissociation of E-Cadherin–Containing Adherens Junctions with Hepatocytes. The American Journal of Pathology 2021; 191(3): 438 doi: 10.1016/j.ajpath.2020.12.007
|
| 5 |
Dina Sabry, Abeer Mostafa, Samar Marzouk, Walaa Ibrahim, Hanan H.M. Ali, Aymen Hassan, Ashraf Shamaa. Neupogen and mesenchymal stem cells are the novel therapeutic agents in regeneration of induced endometrial fibrosis in experimental rats. Bioscience Reports 2017; 37(5) doi: 10.1042/BSR20170794
|
| 6 |
Paula Constanza Arriola Benitez, Ayelén Ivana Pesce Viglietti, Marco Tulio R. Gomes, Sergio Costa Oliveira, Jorge Fabián Quarleri, Guillermo Hernán Giambartolomei, María Victoria Delpino. Brucella abortus Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent IL-1β Production. Frontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.03036
|
| 7 |
Chuangzhen Lin, Bingqing Yu, Lixin Chen, Zhaohui Zhang, Weixiang Ye, Hui Zhong, Wenke Bai, Yuping Yang, Biao Nie. Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.880508
|
| 8 |
Ana C. Maretti-Mira, Matthew P. Salomon, Shefali Chopra, Liyun Yuan, Lucy Golden-Mason. Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression. Biomedicines 2024; 12(5): 1105 doi: 10.3390/biomedicines12051105
|
| 9 |
Hui Yang, Juan Wang, Zhen‐Guo Liu. Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis. Journal of Cellular and Molecular Medicine 2022; 26(10): 2757 doi: 10.1111/jcmm.17277
|
| 10 |
Simon Hohenester, Veronika Kanitz, Tobias Schiergens, Claudia Einer, Jutta Nagel, Ralf Wimmer, Florian P. Reiter, Alexander L. Gerbes, Enrico N. De Toni, Christian Bauer, Lesca Holdt, Doris Mayr, Christian Rust, Max Schnurr, Hans Zischka, Andreas Geier, Gerald Denk. IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(22): 8602 doi: 10.3390/ijms21228602
|
| 11 |
Harsh Vardhan Charan, Durgesh Kumar Dwivedi, Sabbir Khan, Gopabandhu Jena. Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis. Genes & Diseases 2023; 10(2): 480 doi: 10.1016/j.gendis.2021.12.006
|
| 12 |
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East Journal of Digestive Diseases 2018; 10(3): 133 doi: 10.15171/mejdd.2018.103
|
| 13 |
Junwen Qu, Zhiqing Yuan, Guiyang Wang, Xiaopeng Wang, Kewei Li. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. International Immunopharmacology 2019; 70: 147 doi: 10.1016/j.intimp.2019.02.016
|
| 14 |
Steffeni Mountford, Maria Effenberger, Heidi Noll-Puchta, Lucas Griessmair, Andrea Ringleb, Sonja Haas, Gerald Denk, Florian P. Reiter, Doris Mayr, Charles A. Dinarello, Herbert Tilg, Philip Bufler. Modulation of Liver Inflammation and Fibrosis by Interleukin-37. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.603649
|
| 15 |
Guang-Yue Su, Zhi-Yao Li, Rui Wang, Ye-Zhi Lu, Ji-Xing Nan, Yan-Ling Wu, Yu-Qing Zhao. Signaling pathways involved in p38-ERK and inflammatory factors mediated the anti-fibrosis effect of AD-2 on thioacetamide-induced liver injury in mice. Food & Function 2019; 10(7): 3992 doi: 10.1039/C8FO02405G
|
| 16 |
Jie Wang, Sinan Lin, Jonathan Mark Brown, David van Wagoner, Claudio Fiocchi, Florian Rieder. Novel mechanisms and clinical trial endpoints in intestinal fibrosis*. Immunological Reviews 2021; 302(1): 211 doi: 10.1111/imr.12974
|
| 17 |
|
| 18 |
Yan Liu, Xuehua Kong, Yan You, Linwei Xiang, Yan Zhang, Rui Wu, Lan Zhou, Liang Duan. S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression. Cells 2022; 11(22): 3579 doi: 10.3390/cells11223579
|
| 19 |
Liangtao Ye, Andreas Ziesch, Julia S. Schneider, Andrea Ofner, Hanno Nieß, Gerald Denk, Simon Hohenester, Doris Mayr, Ujjwal M. Mahajan, Stefan Munker, Najib Ben Khaled, Ralf Wimmer, Alexander L. Gerbes, Julia Mayerle, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology. Aging and disease 2024; 15(1): 338 doi: 10.14336/AD.2023.0602
|
| 20 |
Nesrine Ebrahim, Ola Mostafa, Rania Ebrahim El Dosoky, Inas A. Ahmed, Ahmed S. Saad, Abeer Mostafa, Dina Sabry, Khalid Abdelaziz Ibrahim, Ayman Samir Farid. Human mesenchymal stem cell-derived extracellular vesicles/estrogen combined therapy safely ameliorates experimentally induced intrauterine adhesions in a female rat model. Stem Cell Research & Therapy 2018; 9(1) doi: 10.1186/s13287-018-0924-z
|
| 21 |
Zixiong Zhou, Jong-Won Kim, Jing Qi, Seong Kug Eo, Chae Woong Lim, Bumseok Kim. Toll-Like Receptor 5 Signaling Ameliorates Liver Fibrosis by Inducing Interferon β–Modulated IL-1 Receptor Antagonist in Mice. The American Journal of Pathology 2020; 190(3): 614 doi: 10.1016/j.ajpath.2019.11.012
|
| 22 |
Ye Tao, Ningning Wang, Tianming Qiu, Xiance Sun. The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7269150
|
| 23 |
Si-Nan Lin, Ren Mao, Chenchen Qian, Dominik Bettenworth, Jie Wang, Jiannan Li, David H. Bruining, Vipul Jairath, Brian G. Feagan, Min-Hu Chen, Florian Rieder. Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases. Physiological Reviews 2022; 102(2): 605 doi: 10.1152/physrev.00005.2021
|
| 24 |
Erika Ramos-Tovar, Pablo Muriel. NLRP3 inflammasome in hepatic diseases: A pharmacological target. Biochemical Pharmacology 2023; 217: 115861 doi: 10.1016/j.bcp.2023.115861
|
| 25 |
Jihye Choi, Yunsang Cho, Hwal Choi, Sangmin Lee, Hyeju Han, Jeonghyeon Lee, Jungkee Kwon. Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways. International Journal of Molecular Sciences 2023; 24(4): 3439 doi: 10.3390/ijms24043439
|
| 26 |
Yipeng Wan, Wang Zhang, Chenkai Huang, Jie Jian, Yue Zhang, Qi Liu, Peng Chen, Xuan Zhu. Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2/NLRP3 inflammasome signaling pathway. International Immunopharmacology 2022; 113: 109321 doi: 10.1016/j.intimp.2022.109321
|
| 27 |
Ting-Ting Chen, Feng Xiao, Nan Li, Shan Shan, Meng Qi, Zi-Ying Wang, Sheng-Nan Zhang, Wei Wei, Wu-Yi Sun. Inflammasome as an Effective Platform for Fibrosis Therapy. Journal of Inflammation Research 2021; : 1575 doi: 10.2147/JIR.S304180
|
| 28 |
Florian Rieder, Pranab K Mukherjee, William J Massey, Yan Wang, Claudio Fiocchi. Fibrosis in IBD: from pathogenesis to therapeutic targets. Gut 2024; : gutjnl-2023-329963 doi: 10.1136/gutjnl-2023-329963
|
| 29 |
Rodrigo C. O. Sanches, Cláudia Souza, Fabio Vitarelli Marinho, Fábio Silva Mambelli, Suellen B. Morais, Erika S. Guimarães, Sergio Costa Oliveira. NLRP6 Plays an Important Role in Early Hepatic Immunopathology Caused by Schistosoma mansoni Infection. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00795
|
| 30 |
Dong-Hyun Kim, Kyeong-Jin Lee, JinJoo Park, Susan Chi, Jaekyu Han, Yewon Bang, Sun-Mi Kim, Seung Goo Kang, Sang-Hoon Cha, Yong-Hyun Han. Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease. Biomedicine & Pharmacotherapy 2023; 167: 115587 doi: 10.1016/j.biopha.2023.115587
|
| 31 |
YONGDAE YOON, SOONJAE HWANG, FATEMA TUJ SAIMA, MOON YOUNG KIM, SOON KOO BAIK, YOUNG WOO EOM. AKT regulates IL-1β-induced proliferation and activation of hepatic stellate cells. BIOCELL 2023; 47(3): 669 doi: 10.32604/biocell.2023.025365
|
| 32 |
Florian P. Reiter, Liangtao Ye, Florian Bösch, Ralf Wimmer, Renate Artmann, Andreas Ziesch, Veronika Kanitz, Doris Mayr, Christian J. Steib, Michael Trauner, Ivonne Regel, Alexander L. Gerbes, Julia Mayerle, Simon Hohenester, Enrico N. de Toni, Gerald Denk. Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model. Laboratory Investigation 2019; 99(12): 1906 doi: 10.1038/s41374-019-0310-1
|
| 33 |
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree. Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology 2023; 77(6): 1968 doi: 10.1002/hep.32776
|